VIVA Biotech Statements
18
VIVA Biotech Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
1 013.39
100
680.93
67.2
332.46
32.8
51.267
5.1
205.82
20.3
250.59
24.7
81.871
8.1
-124.01
-12.2
174.32
17.2
-92.705
-9.1
20.744
2
-117.13
-11.6
-0.06
1 965.51
1 142.18
100
736.22
64.5
405.97
35.5
76.7
6.7
203.84
17.8
253.13
22.2
152.84
13.4
-110.38
-9.7
—
0
36.752
3.2
23.093
2
1.013
0.09
0.001
1 915.44
1 270.88
100
800.18
63
470.71
37
94.918
7.5
206.05
16.2
303.02
23.8
167.68
13.2
-516.29
-40.6
—
0
-395.69
-31.1
23.309
1.8
-437.27
-34.4
-0.228
1 915.44
1 108.75
100
763.77
68.9
344.97
31.1
40.917
3.7
198.41
17.9
217.28
19.6
127.69
11.5
-198.29
-17.9
10.05
0.9
-63.474
-5.7
21.746
2
-91.201
-8.2
-0.048
1 915.44
1 077.63
100
742.93
68.9
334.71
31.1
54.906
5.1
185.18
17.2
213.78
19.8
120.93
11.2
-54.772
-5.08
150.84
14
225.65
20.9
20.889
1.9
202.53
18.8
0.1
2 007.57
1 026.45
100
710.18
69.2
316.27
30.8
37.476
3.7
135.11
13.2
177.09
17.3
139.18
13.6
-3.871
-0.4
-13.366
-1.3
122.05
11.9
26.252
2.6
85.02
8.3
0.044
1 934.03
499.4
100
294.65
59
204.75
41
43.717
8.8
84.259
16.9
157.5
31.5
47.251
9.5
46.279
9.3
68.478
13.7
166.18
33.3
14.781
3
143.39
28.7
0.083
1 735.85
197.56
100
97.439
49.3
100.12
50.7
22.324
11.3
38.999
19.7
57.868
29.3
42.25
21.4
45.725
23.1
-615.53
-311.6
-522.39
-264.4
7.879
4
-530.27
-268.4
-0.377
1 407.17
180.72
100
96.734
53.5
83.982
46.5
29.338
16.2
31.078
17.2
56.37
31.2
27.612
15.3
192.38
106.5
—
0
221.77
122.7
2.393
1.3
219.38
121.4
0.134
1 638.95
142.34
100
70.45
49.5
71.891
50.5
15.616
11
25.52
17.9
39.367
27.7
32.524
22.8
68.9
48.4
-34.238
-24.05
59.156
41.6
12.66
8.9
46.496
32.7
0.035
1 330.94